Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
3.115
-0.015 (-0.48%)
At close: Apr 24, 2026, 4:00 PM EDT
3.050
-0.065 (-2.09%)
After-hours: Apr 24, 2026, 4:04 PM EDT
Xenetic Biosciences Market Cap
Xenetic Biosciences has a market cap or net worth of $7.14 million as of April 24, 2026. Its market cap has increased by 98.24% in one year.
Market Cap
7.14M
Enterprise Value
-889.26K
1-Year Change
98.24%
Ranking
Category
Stock Price
$3.12
Market Cap Chart
Since June 30, 2016, Xenetic Biosciences's market cap has decreased from $47.70M to $7.14M, a decrease of -85.04%. That is a compound annual growth rate of -17.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 7.20M | 44.00% |
| Dec 31, 2025 | 5.00M | -19.35% |
| Dec 31, 2024 | 6.20M | 16.98% |
| Dec 29, 2023 | 5.30M | 23.26% |
| Dec 30, 2022 | 4.30M | -75.14% |
| Dec 31, 2021 | 17.30M | 35.16% |
| Dec 31, 2020 | 12.80M | 54.22% |
| Dec 31, 2019 | 8.30M | -46.10% |
| Dec 31, 2018 | 15.40M | -7.78% |
| Dec 29, 2017 | 16.70M | -53.09% |
| Dec 30, 2016 | 35.60M | -25.37% |
| Jun 30, 2016 | 47.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Indaptus Therapeutics | 7.94M |
| Immuron | 7.73M |
| Processa Pharmaceuticals | 7.36M |
| Aptorum Group | 7.25M |
| Addex Therapeutics | 7.02M |
| FibroBiologics | 6.90M |
| Enveric Biosciences | 6.69M |
| Akari Therapeutics, | 6.64M |